Multi-Omics Analysis Identified TMED2 as a Shared Potential Biomarker in Six Subtypes of Human Cancer

References

• Nagai H, Kim YH. Cancer prevention from the perspective of global cancer burden patterns. J Thorac Dis. 2017;9(3):448–451. doi:10.21037/jtd.2017.02.75
   PubMed Web of Science ®Google Scholar
• Hunter KW, Crawford NPS, Alsarraj J. Mechanisms of metastasis. Breast Cancer Res. 2008;10(Suppl1):S2. doi:10.1186/bcr1988
   PubMedGoogle Scholar
• Ventola CL. Cancer immunotherapy, part 2: efficacy, safety, and other clinical considerations. P T. 2017;42(7):452–463.
   PubMedGoogle Scholar
• Aber R, Chan W, Mugisha S, Jerome-Majewska LA. Transmembrane emp24 domain proteins in development and disease. Genet Res. 2019;101:e14–e14. doi:10.1017/S0016672319000090
   PubMed Web of Science ®Google Scholar
• Lin X, Liu J, Hu SF, Hu X. Increased expression of TMED2 is an unfavorable prognostic factor in patients with breast cancer. Cancer Manag Res. 2019;11:2203–2214. doi:10.2147/CMAR.S192949
   PubMed Web of Science ®Google Scholar
• Duquet A, Melotti A, Mishra S, et al. A novel genome-wide in vivo screen for metastatic suppressors in human colon cancer identifies the positive WNT-TCF pathway modulators TMED3 and SOX12. EMBO Mol Med. 2014;6(7):882–901. doi:10.15252/emmm.201303799
   PubMed Web of Science ®Google Scholar
• Vainio P, Mpindi J-P, Kohonen P, et al. High-throughput transcriptomic and RNAi analysis identifies AIM1, ERGIC1, TMED3 and TPX2 as potential drug targets in prostate cancer. PLoS One. 2012;7(6):e39801–e39801. doi:10.1371/journal.pone.0039801
   PubMed Web of Science ®Google Scholar
• Zheng H, Yang Y, Han J, et al. TMED3 promotes hepatocellular carcinoma progression via IL-11/STAT3 signaling. Sci Rep. 2016;6(1):37070. doi:10.1038/srep37070
   PubMed Web of Science ®Google Scholar
• Chandrashekar DS, Bashel B, Balasubramanya SAH, et al. UALCAN: a portal for facilitating tumor subgroup gene expression and survival analyses. Neoplasia. 2017;19(8):649–658. doi:10.1016/j.neo.2017.05.002
   PubMed Web of Science ®Google Scholar
• Park S-J, Yoon B-H, Kim S-K, Kim S-Y. GENT2: an updated gene expression database for normal and tumor tissues. BMC Med Genom. 2019;12(5):101. doi:10.1186/s12920-019-0514-7
   PubMed Web of Science ®Google Scholar
• Uhlén M, Fagerberg L, Hallström BM, et al. Tissue-based map of the human proteome. Science. 2015;347(6220). doi:10.1126/science.1260419
   PubMed Web of Science ®Google Scholar
• Koch A, De Meyer T, Jeschke J, Van Criekinge W. MEXPRESS: visualizing expression, DNA methylation and clinical TCGA data. BMC Genom. 2015;16(1):636. doi:10.1186/s12864-015-1847-z
   PubMed Web of Science ®Google Scholar
• Cerami E, Gao J, Dogrusoz U, et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2012;2(5):401–404. doi:10.1158/2159-8290.CD-12-0095
   PubMed Web of Science ®Google Scholar
• von Mering C, Huynen M, Jaeggi D, Schmidt S, Bork P, Snel B. STRING: a database of predicted functional associations between proteins. Nucleic Acids Res. 2003;31(1):258–261. doi:10.1093/nar/gkg034
   PubMed Web of Science ®Google Scholar
• Shannon P, Markiel A, Ozier O, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003;13(11):2498–2504. doi:10.1101/gr.1239303
   PubMed Web of Science ®Google Scholar
• Huang DW, Sherman BT, Tan Q, et al. The DAVID gene functional classification tool: a novel biological module-centric algorithm to functionally analyze large gene lists. Genome Biol. 2007;8(9):R183–R183. doi:10.1186/gb-2007-8-9-r183
   PubMed Web of Science ®Google Scholar
• Li T, Fu J, Zeng Z, et al. TIMER2.0 for analysis of tumor-infiltrating immune cells. Nucleic Acids Res. 2020;48(W1):W509–W514. doi:10.1093/nar/gkaa407
   PubMed Web of Science ®Google Scholar
• Mattingly CJ, Colby GT, Forrest JN, Boyer JL. The Comparative Toxicogenomics Database (CTD). Environ Health Perspect. 2003;111(6):793–795. doi:10.1289/ehp.6028
   PubMed Web of Science ®Google Scholar
• Luczak MW, Jagodziński PP. The role of DNA methylation in cancer development. Folia Histochem Cytobiol. 2006;44(3):143–154.
   PubMed Web of Science ®Google Scholar
• Hou W, Gupta S, Beauchamp M-C, Yuan L, Jerome-Majewska LA. Non-alcoholic fatty liver disease in mice with heterozygous mutation in TMED2. PLoS One. 2017;12(8):e0182995–e0182995. doi:10.1371/journal.pone.0182995
   PubMed Web of Science ®Google Scholar
• Teschendorff AE, Relton CL. Statistical and integrative system-level analysis of DNA methylation data. Nat Rev Genet. 2018;19(3):129. doi:10.1038/nrg.2017.86
   PubMed Web of Science ®Google Scholar
• Jung G, Hernández-Illán E, Moreira L, Balaguer F, Goel A. Epigenetics of colorectal cancer: biomarker and therapeutic potential. Nat Rev Gastroenterol Hepatol. 2020;17(2):111–130. doi:10.1038/s41575-019-0230-y
   PubMed Web of Science ®Google Scholar
• Iancu IV, Botezatu A, Plesa A, et al. Alterations of regulatory factors and DNA methylation pattern in thyroid cancer. Cancer Biomark. 2020;28(2):1–14.
   PubMed Web of Science ®Google Scholar
• Gào X, Zhang Y, Burwinkel B, et al. The associations of DNA methylation alterations in oxidative stress-related genes with cancer incidence and mortality outcomes: a population-based cohort study. Clin Epigenetics. 2019;11(1):1–9. doi:10.1186/s13148-018-0604-y
   PubMed Web of Science ®Google Scholar
• Knuutila S, Björkqvist A-M, Autio K, et al. DNA copy number amplifications in human neoplasms: review of comparative genomic hybridization studies. Am J Pathol. 1998;152(5):1107.
   PubMed Web of Science ®Google Scholar
• Brison O. Gene amplification and tumor progression. Biochim Biophys Acta Rev Cancer. 1993;1155(1):25–41. doi:10.1016/0304-419X(93)90020-D
   Web of Science ®Google Scholar
• He Y, Hu S, Zhong J, Cheng A, Shan N. Identification of significant genes signatures and prognostic biomarkers in cervical squamous carcinoma via bioinformatic data. PeerJ. 2020;8:e10386–e10386. doi:10.7717/peerj.10386
   PubMed Web of Science ®Google Scholar
• Ding H, Xiong -X-X, Fan G-L, et al. The new biomarker for cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma (CESC) based on public database mining. Biomed Res Int. 2020;2020:5478574. doi:10.1155/2020/5478574
   PubMed Web of Science ®Google Scholar
• Wang Z, Chen M, Qiu Y, et al. Identification of potential biomarkers associated with immune infiltration in the esophageal carcinoma tumor microenvironment. Biosci Rep. 2021;41(2). doi:10.1042/BSR20202439
   Web of Science ®Google Scholar
• Wang L, Li X, Zhao L, et al. Identification of DNA-repair-related five-gene signature to predict prognosis in patients with esophageal cancer. Pathol Oncol Res. 2021;27:25. doi:10.3389/pore.2021.596899
   Web of Science ®Google Scholar
• Jiang P, He S, Li Y, Xu Z. Identification of therapeutic and prognostic biomarkers of Lamin C (LAMC) family members in head and neck squamous cell carcinoma. Med Sci Monitor. 2020;26:e925735. doi:10.12659/MSM.925735
   PubMed Web of Science ®Google Scholar
• Dong Y, Lu S, Wang Z, Liu L. CCTs as new biomarkers for the prognosis of head and neck squamous cancer. Open Med. 2020;15(1):672–688. doi:10.1515/med-2020-0114
   Web of Science ®Google Scholar
• Li Y, Wu L, Tao W, Wu D, Ma F, Li N. Expression atlas of FGF and FGFR genes in pancancer uncovered predictive biomarkers for clinical trials of selective FGFR inhibitors. Biomed Res Int. 2020;2020:5658904.
   PubMed Web of Science ®Google Scholar
• Jiang M, Lin J, Xing H, et al. Microenvironment-related gene TNFSF13B predicts poor prognosis in kidney renal clear cell carcinoma. PeerJ. 2020;8:e9453. doi:10.7717/peerj.9453
   PubMed Web of Science ®Google Scholar
• Chen G, Wang Y, Wang L, Xu W. Identifying prognostic biomarkers based on aberrant DNA methylation in kidney renal clear cell carcinoma. Oncotarget. 2017;8(3):5268. doi:10.18632/oncotarget.14134
   PubMedGoogle Scholar
• Deng M, Liang H, Hu K, et al. Novel prognostic markers for liver hepatocellular carcinoma and their roles in Immune infiltration of the tumor microenvironment; 2021.
   Google Scholar
• Chen J, Yang J, Xu Q, et al. Integrated bioinformatics analysis identified MTHFD1L as a potential biomarker and correlated with immune infiltrates in hepatocellular carcinoma. Biosci Rep. 2021;41(2):BSR20202063. doi:10.1042/BSR20202063
   PubMed Web of Science ®Google Scholar
• Li J, Liu X, Cui Z, Han G. Comprehensive analysis of candidate diagnostic and prognostic biomarkers associated with lung adenocarcinoma. Med Sci Monitor. 2020;26:e922070–e922070.
   PubMed Web of Science ®Google Scholar
• Casey SC, Baylot V, Felsher DW. The MYC oncogene is a global regulator of the immune response. Blood. 2018;131(18):2007–2015. doi:10.1182/blood-2017-11-742577
   PubMed Web of Science ®Google Scholar
• Ghatalia P, Gordetsky J, Kuo F, et al. Correction to: prognostic impact of immune gene expression signature and tumor infiltrating immune cells in localized clear cell renal cell carcinoma. J Immunother Cancer. 2019;7(1):273.
   PubMed Web of Science ®Google Scholar